Prof. Dr. Rainer Fietkau



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

The long-term influence of hospital and surgeon volume on local control and survival in the randomized German Rectal Cancer Trial CAO/ARO/AIO-94 (2020) Sprenger T, Beissbarth T, Sauer R, Tschmelitsch J, Fietkau R, Hohenberger W, Staib L, et al. Journal article Dual mtor/dna-pk inhibitor cc-115 induces cell death in melanoma cells and has radiosensitizing potential (2020) Bürkel F, Jost T, Hecht M, Heinzerling L, Fietkau R, Distel L Journal article Role of tumor cell senescence in non-professional phagocytosis and cell-in-cell structure formation (2020) Gottwald D, Putz F, Hohmann N, Büttner-Herold M, Hecht M, Fietkau R, Distel L Journal article Ex vivo radiosensitivity is increased in non-cancer patients taking valproate (2020) Stritzelberger J, Lainer J, Gollwitzer S, Graf W, Jost T, Lang J, Müller T, et al. Journal article Radiomics for selection of patients treated with immuno-radiotherapy: pooled analysis from 6 studies (2020) Sun R, Sundahl N, Hecht M, Putz F, Lancia A, Milic M, Carre A, et al. Conference contribution ROI optimisation for surface guided radiation therapy (2020) Sauer TO, Popp D, Fietkau R, Bert C Conference contribution Volumetric regression in brain metastases after stereotactic RT: Time course and significance (2020) Putz F, Oft D, Perrin R, Mengling V, Weissmann T, Roesch J, Mansoorian S, et al. Conference contribution Reactivation of HCMV during RT of the brain results in critical illness and early mortality (2020) Frey B, Goerig N, Becker I, Donaubauer AJ, Korn K, Überla K, Schmidt M, et al. Conference contribution Comparison of MRI coils and RT-positioning systems for optimal MRI scanning in SRS cases (2020) Mengling V, Perrin R, Putz F, Fietkau R, Bert C Conference contribution Development of a flow cytometry-based whole-blood prognostic immune signature in metastatic cancer patients treated with immune checkpoint inhibitors (2020) Zhou J, Donaubauer AJ, Frey B, Becker I, Rutzner S, Eckstein M, Sun R, et al. Conference contribution